KemPharm Inc. (NASDAQ:KMPH) has a beta value of 3.31 and has seen 0.34 million shares traded in the last trading session. The company, currently valued at $330.38M, closed the last trade at $9.59 per share which meant it gained $0.19 on the day or 2.02% during that session. The KMPH stock price is -130.24% off its 52-week high price of $22.08 and 47.13% above the 52-week low of $5.07. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.49 million shares traded. The 3-month trading volume is 781.17K shares.
The consensus among analysts is that KemPharm Inc. (KMPH) is an Overweight stock at the moment, with a recommendation rating of 2.50. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 1 out of 2 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is $0.22.
KemPharm Inc. (NASDAQ:KMPH) trade information
Sporting 2.02% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Friday, 09/03/21 when the KMPH stock price touched $9.59 or saw a rise of 0.42%. Year-to-date, KemPharm Inc. shares have moved -14.37%, while the 5-day performance has seen it change 8.00%. Over the past 30 days, the shares of KemPharm Inc. (NASDAQ:KMPH) have changed -1.94%. Short interest in the company has seen 3.55 million shares shorted with days to cover at 6.11.
Wall Street analysts have a consensus price target for the stock at $19.00, which means that the shares’ value could jump 49.53% from current levels. The projected low price target is $10.00 while the price target rests at a high of $28.00. In that case, then, we find that the current price level is -191.97% off the targeted high while a plunge would see the stock gain -4.28% from current levels.
KemPharm Inc. (KMPH) estimates and forecasts
Figures show that KemPharm Inc. shares have outperformed across the wider relevant industry. The company’s shares have gained 2.79% over the past 6 months, with this year growth rate of 69.67%, compared to 18.50% for the industry. Other than that, the company has, however, increased its growth outlook for the 2021 fiscal year revenue. Growth estimates for the current quarter are 37.50% and 89.10% for the next quarter. Revenue growth from the last financial year stood is estimated to be 114.90%.
2 analysts offering their estimates for the company have set an average revenue estimate of $12.1 million for the current quarter. 2 have an estimated revenue figure of $2.18 million for the next quarter concluding in Sep 2021. Year-ago sales stood $6.91 million and $1.93 million respectively for this quarter and the next, and analysts expect sales will grow by 75.20% for the current quarter and 13.20% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 51.40% over the past 5 years.
KemPharm Inc. is expected to release its next earnings report between August 10 and August 16 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
KemPharm Inc. (NASDAQ:KMPH)’s Major holders
Insiders own 14.73% of the company shares, while shares held by institutions stand at 16.03% with a share float percentage of 18.80%. Investors are also buoyed by the number of investors in a company, with KemPharm Inc. having a total of 58 institutions that hold shares in the company. The top two institutional holders are Vanguard Group, Inc. (The) with over 0.82 million shares worth more than $7.52 million. As of Mar 30, 2021, Vanguard Group, Inc. (The) held 18.95% of shares outstanding.
The other major institutional holder is Millennium Management LLC, with the holding of over 0.21 million shares as of Mar 30, 2021. The firm’s total holdings are worth over $1.96 million and represent 4.93% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of Mar 30, 2021, the former fund manager holds about 12.14% shares in the company for having 0.52 million shares of worth $4.82 million while later fund manager owns 0.27 million shares of worth $2.47 million as of Mar 30, 2021, which makes it owner of about 6.23% of company’s outstanding stock.